Showing results (1-10 of 346) with videos related to
Sort By:
Pageof 35
The Journal of Antimicrobial Chemotherapy|April 6, 2019
Introduction: lefamulin and pharmacokinetic/pharmacodynamic rationale to support the dose selection of lefamulinKeith A RodvoldJournal of Managed Care Pharmacy : JMCP|June 10, 2009
Collaborative strategies for improving clinical resource utilization: how pharmacists can make a differenceKeith A RodvoldExpert Opinion on Pharmacotherapy|March 4, 2008
The role of carbapenems in the treatment of severe nosocomial respiratory tract infectionsJomy Joseph, Keith A RodvoldClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2015
Telavancin: the long and winding road from discovery to food and drug administration approvals and future directionsEric Wenzler, Keith A RodvoldCritical Care Medicine|February 27, 2009
Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unitAndrew F ShorrClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 19, 2007
Epidemiology of staphylococcal resistanceAndrew F ShorrClinics in Chest Medicine|April 2, 2005
Preventing pneumonia: the role for pneumococcal and influenza vaccinesAndrew F ShorrPharmacoeconomics|September 7, 2007
Epidemiology and economic impact of meticillin-resistant Staphylococcus aureus: review and analysis of the literatureAndrew F ShorrThe American Journal of Medicine|October 16, 2007
The pharmacoeconomics of deep vein thrombosis treatmentAndrew F ShorrCurrent Opinion in Critical Care|October 19, 2002
An update on cost-effectiveness analysis in critical careAndrew F ShorrPageof 35